Seer (SEER) Shares Outstanding (Diluted Average) (2020 - 2026)
Seer (SEER) recorded quarterly Shares Outstanding (Diluted Average) of $56.0 million in Q1 2026, down 2.53% quarter-over-quarter from $57.4 million in Q4 2025, and down 5.74% on a YoY basis from $59.4 million in Q1 2025.
Seer (SEER) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
Seer's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $56.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 5.74% year-over-year to $56.0 million; the TTM figure through Mar 2026 stood at $56.0 million (down 5.74% YoY), while the FY2025 annual figure was $57.4 million, down 7.86% from the prior year.
- Shares Outstanding (Diluted Average) was $56.0 million for Q1 2026 at Seer, down from $57.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $64.6 million in Q1 2024 to a low of $56.0 million in Q1 2026.
- Historically, Shares Outstanding (Diluted Average) has averaged $61.6 million across 5 years, with a median of $62.3 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) increased 3.53% in 2022, then declined 10.05% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $62.4 million in 2022, then advanced by 2.27% to $63.9 million in 2023, then declined by 2.35% to $62.3 million in 2024, then slipped by 7.86% to $57.4 million in 2025, then fell by 2.53% to $56.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $56.0 million (Q1 2026), $57.4 million (Q4 2025), and $57.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 92.44 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 56.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.00 Mn |
| Dec 31, 2025 | 57.45 Mn |
| Sep 30, 2025 | 57.93 Mn |
| Jun 30, 2025 | 58.09 Mn |
| Mar 31, 2025 | 59.41 Mn |
| Dec 31, 2024 | 62.35 Mn |
| Sep 30, 2024 | 63.44 Mn |
| Jun 30, 2024 | 64.58 Mn |
| Mar 31, 2024 | 64.59 Mn |
| Dec 31, 2023 | 63.85 Mn |
| Sep 30, 2023 | 63.93 Mn |
| Jun 30, 2023 | 63.65 Mn |
| Mar 31, 2023 | 63.54 Mn |
| Dec 31, 2022 | 62.43 Mn |
| Sep 30, 2022 | 62.31 Mn |
| Jun 30, 2022 | 62.19 Mn |
| Mar 31, 2022 | 62.00 Mn |
| Dec 31, 2021 | 60.86 Mn |
| Sep 30, 2021 | 61.13 Mn |
| Jun 30, 2021 | 60.84 Mn |